Approval · Notice of Compliance 25600 · 2021
VITRECTO: Notice of Compliance 25600
Issued April 7, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25600
- Date
- April 7, 2021
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new manufacturing site, Manufacturing changes for the drug substance - Moxidectin
Products in this notice
Medicinal ingredients
- MOXIDECTIN 5.6 MG per 0.4ML
- FLURALANER 112.5 MG per 0.4ML
- MOXIDECTIN 12.5 MG per 0.89ML
- FLURALANER 250 MG per 0.89ML
- MOXIDECTIN 25 MG per 1.79ML
- FLURALANER 500 MG per 1.79ML